Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion
| Parent link: | International Journal of Molecular Sciences.— .— Basel: MDPI AG Vol. 25, iss. 8.— 2024.— Article number 4246, 17 p. |
|---|---|
| Other Authors: | Deev S. M. Sergey Mikhaylovich, Oroujeni M. Maryam, Garousi J. Javad, Gräslund T. Torbjörn, Li R. Ruonan, Rosly A. H. B. Alia Hani Binti, Orlova A. M. Anna Markovna, Konovalova E. V. Elena Valerjevna, Shulga (Schulga) A. A. Aleksey Anatolievich, Vorobjeva (Vorobyeva) A. G. Anzhelika Grigorjevna, Tolmachev V. M. Vladimir Maksimilianovich |
| Summary: | Title screen Designed ankyrin repeat protein (DARPin) G3 is an engineered scaffold protein. This small (14.5 kDa) targeting protein binds with high affinity to human epidermal growth factor receptor 2 (HER2). HER2 is overexpressed in several cancers. The use of the DARPin G3 for radionuclide therapy is complicated by its high renal reabsorption after clearance via the glomeruli. We tested the hypothesis that a fusion of the DARPin G3 with an albumin-binding domain (ABD) would prevent rapid renal excretion and high renal reabsorption resulting in better tumour targeting. Two fusion proteins were produced, one with the ABD at the C-terminus (G3-ABD) and another at the N-terminus (ABD-G3). Both variants were labelled with 177Lu. The binding properties of the novel constructs were evaluated in vitro and their biodistribution was compared in mice with implanted human HER2-expressing tumours. Fusion with the ABD increased the retention time of both constructs in blood compared with the non-ABD-fused control. The effect of fusion with the ABD depended strongly on the order of the domains in the constructs, resulting in appreciably better targeting properties of [177Lu]Lu-G3-ABD. Our data suggest that the order of domains is critical for the design of targeting constructs based on scaffold proteins. Текстовый файл |
| Language: | English |
| Published: |
2024
|
| Subjects: | |
| Online Access: | https://doi.org/10.3390/ijms25084246 |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=672867 |
Similar Items
Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model
Published: (2020)
Published: (2020)
Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation
Published: (2024)
Published: (2024)
Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab
Published: (2023)
Published: (2023)
Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model
Published: (2020)
Published: (2020)
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
Published: (2020)
Published: (2020)
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
Published: (2023)
Published: (2023)
Влияние расположения ABD на таргетные свойства нового бивалентного терапевтического конъюгата на основе DARPin G3
by: Прач А. А. Анастасия Александровна
Published: (2024)
by: Прач А. А. Анастасия Александровна
Published: (2024)
Технологические аспекты выделения LU-177 из иттербиевой мишени
by: Ушаков И. А. Иван Алексеевич
Published: (2023)
by: Ушаков И. А. Иван Алексеевич
Published: (2023)
Расчет поглощённой дозы в ионообменной смоле при разделении лютеция-177 от иттербия с использованием программного комплекса GEANT4
by: Чертков М. С.
Published: (2023)
by: Чертков М. С.
Published: (2023)
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors
Published: (2024)
Published: (2024)
Особенности получения радионуклида лютеций-177 на реакторе ИРТ-Т
Published: (2015)
Published: (2015)
Особенности получения радионуклида лютеций-177 на реакторе ИРТ-Т
by: Зукау В. В. Валерий Викторович
Published: (2014)
by: Зукау В. В. Валерий Викторович
Published: (2014)
Разделение нуклидов 177Lu и Yb методом цементации
by: Ушаков И. А. Иван Алексеевич
Published: (2021)
by: Ушаков И. А. Иван Алексеевич
Published: (2021)
HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model
Published: (2019)
Published: (2019)
Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin
Published: (2019)
Published: (2019)
Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors
Published: (2025)
Published: (2025)
Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer
Published: (2023)
Published: (2023)
Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3, for Imaging of HER2-Positive Breast Cancer
Published: (2023)
Published: (2023)
Авиационное электрорадиоматериаловедение учебник
by: Коровский Ш. Я. Шлема Яковлевич
Published: (Москва, Машиностроение, 1972)
by: Коровский Ш. Я. Шлема Яковлевич
Published: (Москва, Машиностроение, 1972)
Сравнение in vitro конъюгатов аффибоди для HER-2 терапии, содержащих альбумин-связывающий домен и полипептид PAS
by: Боденко В. В. Виталина Васильевна
Published: (2023)
by: Боденко В. В. Виталина Васильевна
Published: (2023)
On the prevention of kidney uptake of radiolabeled DARPins
Published: (2020)
Published: (2020)
Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules
Published: (2020)
Published: (2020)
Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules
Published: (2020)
Published: (2020)
HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution
Published: (2020)
Published: (2020)
Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
Published: (2020)
Published: (2020)
Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties
Published: (2019)
Published: (2019)
Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
Published: (2020)
Published: (2020)
Luminescence properties of color tunable new garnet structure (Lu1-xMnx)3Al2(Al1-xSix)3O12: Ce3+ solid solution phosphors
Published: (2019)
Published: (2019)
Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
Published: (2020)
Published: (2020)
The science of complexity in the tourism domain: a perspective article
by: Baggio R. Rodolfo
Published: (2019)
by: Baggio R. Rodolfo
Published: (2019)
Analysis and Design of Nonlinear Systems in the Frequency Domain
by: Zhu, Yunpeng
Published: (2021)
by: Zhu, Yunpeng
Published: (2021)
Integer points in domains and adiabatic limits
by: Kordyukov Yu. A. Yuri Arkadievich
Published: (2012)
by: Kordyukov Yu. A. Yuri Arkadievich
Published: (2012)
Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
Published: (2020)
Published: (2020)
Radiolabeled Complex of Antimicrobial Peptides UBI29-41 and UBI18-35 Labeled with 99mTc for Differential Diagnosis of Bone Infection of the Limbs
Published: (2021)
Published: (2021)
Single-Photon Emission Computer Tomography Imaging of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Cancer Patients Using a Novel Peptide-Based Probe [99mTc]Tc-BQ0413 with Picomolar Affinity to PSMA: A Phase I/II Clinical Study
Published: (2025)
Published: (2025)
Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
Published: (2021)
Published: (2021)
A novel reference-free technique for processing one-sided thermal NDT results in the time domain
Published: (2024)
Published: (2024)
The number of integer points in a family of anisotropically expanding domains
by: Kordyukov Yu. A. Yuri Arkadievich
Published: (2015)
by: Kordyukov Yu. A. Yuri Arkadievich
Published: (2015)
The Frequency-Domain Algorithm for Ultrasonic Imaging of Complex-Shaped Objects
by: Dolmatov D. O. Dmitry Olegovich
Published: (2018)
by: Dolmatov D. O. Dmitry Olegovich
Published: (2018)
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?
Published: (2025)
Published: (2025)
Similar Items
-
Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model
Published: (2020) -
Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation
Published: (2024) -
Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab
Published: (2023) -
Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model
Published: (2020) -
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
Published: (2020)